Simple Summary Although a notable evolution was recorded in the field of cancer, both in
terms of therapeutic options and diagnostic tools, with nanotechnology contributing …

177Lu is a radioisotope that has become increasingly popular as a therapeutic agent for
treating various conditions, including neuroendocrine tumors and metastatic prostate …

Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine
subspecialty. For many decades, treatment with radionuclides has been mainly restricted to …

Radiotheranostics refers to the pairing of radioactive imaging biomarkers with radioactive
therapeutic compounds that deliver ionizing radiation. Given the introduction of very …

The approval of 223 RaCl 2 for cancer therapy in 2013 has heralded a resurgence of
interest in the development of α-particle emitting radiopharmaceuticals. In the last decade …

In this work, we present details and initial results from a 177 Lu dosimetry challenge that has
been designed to collect data from the global nuclear medicine community aiming at …

Training end-to-end unrolled iterative neural networks for single-photon emission
computerized tomography (SPECT) image reconstruction requires a memory-efficient …

Targeted radionuclide therapy based on α-emitters plays an increasingly important role in
cancer treatment. In this study, we proposed to apply a heterodimeric peptide (iRGD-C6-lys …

This Roadmap paper covers the field of precision preclinical x-ray radiation studies in
animal models. It is mostly focused on models for cancer and normal tissue response to …

Introduction Computational models yield valuable insights into biological interactions not
fully elucidated by experimental approaches. This study investigates an innovative …